Molekule Group Stock Price To Earnings To Growth
MKULDelisted Stock | 2.25 0.15 7.14% |
Molekule Group fundamentals help investors to digest information that contributes to Molekule's financial success or failures. It also enables traders to predict the movement of Molekule Stock. The fundamental analysis module provides a way to measure Molekule's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molekule stock.
Molekule |
Molekule Group Company Price To Earnings To Growth Analysis
Molekule's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Molekule Group has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Machinery sector and 100.0% lower than that of the Industrials industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Molekule Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in price to earnings to growth category among its peers.
Molekule Fundamentals
Return On Equity | -1.17 | |||
Return On Asset | -0.25 | |||
Profit Margin | (1.53) % | |||
Operating Margin | (1.47) % | |||
Current Valuation | 45.01 M | |||
Shares Outstanding | 34.65 M | |||
Shares Owned By Insiders | 33.02 % | |||
Shares Owned By Institutions | 30.70 % | |||
Number Of Shares Shorted | 775.6 K | |||
Revenue | 48.03 M | |||
Gross Profit | 277.62 K | |||
EBITDA | 8.34 M | |||
Net Income | (1.55 M) | |||
Total Debt | 46.72 M | |||
Book Value Per Share | 1.20 X | |||
Cash Flow From Operations | (41.28 M) | |||
Short Ratio | 0.78 X | |||
Earnings Per Share | (0.68) X | |||
Target Price | 7.0 | |||
Number Of Employees | 91 | |||
Market Capitalization | 1.87 M | |||
Total Asset | 52.32 M | |||
Retained Earnings | (7.92 M) | |||
Working Capital | 20.22 M | |||
Z Score | 1.72 | |||
Net Asset | 52.32 M |
About Molekule Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molekule Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molekule using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molekule Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |